FDA investigates death after colistimethate inhalation

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1159, 2007-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Death after Relenza Inhalation Powder was solubilised

By  

Reactions Weekly, Vol. 1, Iss. 1274, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Death of a healthy research subject after an inhalation study – old lessons to be re-learned

By NJC S.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 167-168

Adis International

Access to resources Recommend Favorite

FDA launches initiative for safe use of inhalation drugs in kids

By  

Reactions Weekly, Vol. 1, Iss. 1244, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

FDA updates labelling for dronedarone with CV, death risk

By  

Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Mephenesin: First report of death and bronchial inhalation syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1138, 2007-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite